|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
73,780,000 |
Market
Cap: |
1.35(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$15.13 - $44.56 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 8.9 |
Insider 3/6 Months : 9.5 |
|
Guru Rank Number : 1144 |
Guru Rank Value : 0 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies. Co.'s clinical development programs include: CDX-0159, which is a human monoclonal antibody that specifically binds the receptor tyrosine kinase KIT; CDX-1140, which is a human monoclonal antibody targeted to CD40, a key activator of immune response, which is being studied in a Phase1 study; and CDX-527, which is a bispecific antibody that uses Co.'s proprietary anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway, for which Co. has initiated a Phase 1 study in advanced solid tumors.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
11,500 |
11,500 |
11,500 |
Total Buy Value |
$0 |
$308,430 |
$308,430 |
$308,430 |
Total People Bought |
0 |
1 |
1 |
1 |
Total Buy Transactions |
0 |
1 |
1 |
1 |
Total Shares Sold |
0 |
0 |
353,560 |
353,560 |
Total Sell Value |
$0 |
$0 |
$12,092,086 |
$12,092,086 |
Total People Sold |
0 |
0 |
7 |
7 |
Total Sell Transactions |
0 |
0 |
11 |
11 |
End Date |
2025-01-19 |
2024-10-18 |
2024-04-19 |
2023-04-20 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Marino James J |
|
|
2024-11-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,500 |
2,204 |
|
- |
|
Marucci Anthony S |
PRESIDENT & CEO |
|
2024-11-11 |
4 |
B |
$26.82 |
$308,430 |
D/D |
11,500 |
40,284 |
0.01 |
-23% |
|
Crowley Elizabeth |
SR. VP & CPDO |
|
2024-06-14 |
4 |
S |
$34.87 |
$1,045,962 |
D/D |
(30,000) |
9,074 |
|
19% |
|
Crowley Elizabeth |
SR. VP & CPDO |
|
2024-06-14 |
4 |
OE |
$10.38 |
$311,400 |
D/D |
30,000 |
39,074 |
|
- |
|
Martin Samuel Bates |
SVP AND CFO |
|
2024-06-14 |
4 |
S |
$35.42 |
$608,315 |
D/D |
(17,172) |
28,125 |
|
19% |
|
Martin Samuel Bates |
SVP AND CFO |
|
2024-06-14 |
4 |
OE |
$9.02 |
$204,990 |
D/D |
20,169 |
45,297 |
|
- |
|
Young Diane C. |
SVP, CHIEF MEDICAL OFFICER |
|
2024-06-11 |
4 |
OE |
$2.71 |
$40,650 |
D/D |
15,000 |
17,115 |
|
- |
|
Crowley Elizabeth |
SR. VP & CPDO |
|
2024-06-07 |
4 |
S |
$35.06 |
$525,873 |
D/D |
(15,000) |
9,074 |
|
19% |
|
Crowley Elizabeth |
SR. VP & CPDO |
|
2024-06-07 |
4 |
OE |
$9.02 |
$145,474 |
D/D |
15,000 |
24,074 |
|
- |
|
Young Diane C. |
SVP, CHIEF MEDICAL OFFICER |
|
2024-06-07 |
4 |
S |
$35.26 |
$1,586,844 |
D/D |
(45,000) |
2,115 |
|
19% |
|
Jimenez Freddy A. |
SVP & GENERAL COUNSEL |
|
2024-06-05 |
4 |
OE |
$10.38 |
$99,025 |
D/D |
9,540 |
35,464 |
|
- |
|
Heath-Chiozzi Margo |
SVP OF REGULATORY AFFAIRS |
|
2024-06-03 |
4 |
S |
$33.65 |
$1,964,088 |
D/D |
(58,369) |
13,383 |
|
6% |
|
Heath-Chiozzi Margo |
SVP OF REGULATORY AFFAIRS |
|
2024-06-03 |
4 |
OE |
$9.02 |
$662,575 |
D/D |
64,658 |
71,752 |
|
- |
|
Wright Richard M. |
SR. VP & CCO |
|
2024-06-03 |
4 |
S |
$33.53 |
$1,579,353 |
D/D |
(46,844) |
20,833 |
|
6% |
|
Wright Richard M. |
SR. VP & CCO |
|
2024-06-03 |
4 |
OE |
$2.78 |
$1,267,540 |
D/D |
67,469 |
67,677 |
|
- |
|
Jimenez Freddy A. |
SVP & GENERAL COUNSEL |
|
2024-06-03 |
4 |
S |
$33.60 |
$269,002 |
D/D |
(8,006) |
25,924 |
|
6% |
|
Jimenez Freddy A. |
SVP & GENERAL COUNSEL |
|
2024-06-03 |
4 |
OE |
$10.38 |
$83,102 |
D/D |
8,006 |
33,930 |
|
- |
|
Cavanaugh Sarah |
SVP OF CORP AFFAIRS & ADMIN. |
|
2024-05-30 |
4 |
S |
$33.73 |
$703,334 |
D/D |
(20,853) |
1,860 |
|
11% |
|
Cavanaugh Sarah |
SVP OF CORP AFFAIRS & ADMIN. |
|
2024-05-30 |
4 |
OE |
$2.78 |
$120,979 |
D/D |
20,853 |
22,713 |
|
- |
|
Crowley Elizabeth |
SR. VP & CPDO |
|
2024-05-30 |
4 |
S |
$33.64 |
$1,298,384 |
D/D |
(38,597) |
9,074 |
|
11% |
|
Crowley Elizabeth |
SR. VP & CPDO |
|
2024-05-30 |
4 |
OE |
$2.78 |
$172,397 |
D/D |
42,945 |
47,671 |
|
- |
|
Martin Samuel Bates |
SVP AND CFO |
|
2024-05-30 |
4 |
S |
$34.05 |
$1,191,775 |
D/D |
(35,000) |
25,128 |
|
11% |
|
Martin Samuel Bates |
SVP AND CFO |
|
2024-05-30 |
4 |
OE |
$10.38 |
$259,500 |
D/D |
25,000 |
60,128 |
|
- |
|
Heath-Chiozzi Margo |
SVP OF REGULATORY AFFAIRS |
|
2024-05-30 |
4 |
S |
$34.07 |
$1,319,156 |
D/D |
(38,719) |
7,094 |
|
11% |
|
Heath-Chiozzi Margo |
SVP OF REGULATORY AFFAIRS |
|
2024-05-30 |
4 |
OE |
$2.78 |
$126,301 |
D/D |
33,719 |
45,813 |
|
- |
|
137 Records found
|
|
Page 1 of 6 |
|
|